Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IM-12 是一种 GSK-3β的抑制剂,其 IC50=53 nM,可提高 Wnt 信号传导。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 182 | 现货 | ||
5 mg | ¥ 389 | 现货 | ||
10 mg | ¥ 558 | 现货 | ||
25 mg | ¥ 1,130 | 现货 | ||
50 mg | ¥ 2,190 | 现货 | ||
100 mg | ¥ 3,820 | 现货 | ||
500 mg | ¥ 8,460 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 439 | 现货 |
产品描述 | IM-12, an effective GSK-3β inhibitor(IC50=53 nM), regulates Wnt signalling. |
靶点活性 | GSK-3β:53 nM |
体内活性 | 在hNPCs中(IC50=3.8 μM),IM-12能够抑制GSK-3β活性,增加β-连环蛋白浓度。在人神经祖细胞中,IM-12通过对于Wnt信号通路的激活,促进细胞增殖。 |
激酶实验 | GSK-3β activity assay: IC50 of new synthesised compound IM-12 to GSK-3β is determined by a luminometric GSK-3β activity assay. Briefly, compounds are tested in different concentrations diluted in assay buffer containing final concentrations of: 4 mM MOPS pH 7.2; 0.4 mM EDTA; 1 mM EGTA; 2.5 mM β-glycerophosphate; 4 mM MgCl2; 40 μM BSA; 0.05 mM DTT. Four microlitres of diluted compounds are added to 25 μM pGS-2 peptide substrate, 20 ng recombinant GSK-3β and 1 μM ATP to a total assay volume of 40 μl. The enzymatic reaction is stopped after 30 min of incubation at 30 °C by adding 40 μl KinaseGlo. The luminometric signal is allowed to stabilise for 10 min and the measured with a Glomax? 96 Microplate Luminometer. |
细胞实验 | To measure viable cells, 50-100 μL of cell suspension is analyzed using CASY technology with the appropriate program. ReNcell VM cells are seeded at a defined cell number and proliferated for 24 h. Then the medium is changed to proliferation medium with added substances at indicated concentrations. The cell number was determined every 24 h. Cells were exposed to the added drugs during the whole experiment, whereas the media is changed every 24 h.(Only for Reference) |
别名 | IM 12 |
分子量 | 377.41 |
分子式 | C22H20FN3O2 |
CAS No. | 1129669-05-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 70 mg/mL (185.5 mM)
Ethanol: 10 mg/mL (26.49 mM), Heating is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.6496 mL | 13.2482 mL | 26.4964 mL | 66.241 mL |
5 mM | 0.5299 mL | 2.6496 mL | 5.2993 mL | 13.2482 mL | |
10 mM | 0.265 mL | 1.3248 mL | 2.6496 mL | 6.6241 mL | |
20 mM | 0.1325 mL | 0.6624 mL | 1.3248 mL | 3.312 mL | |
DMSO | 50 mM | 0.053 mL | 0.265 mL | 0.5299 mL | 1.3248 mL |
100 mM | 0.0265 mL | 0.1325 mL | 0.265 mL | 0.6624 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IM-12 1129669-05-1 PI3K/Akt/mTOR signaling Stem Cells GSK-3 Glycogen synthase kinase-3 Glycogen synthase kinase 3 Inhibitor inhibit IM12 IM 12 inhibitor